# Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation

> **NCT04171726** · PHASE3 · UNKNOWN · sponsor: **Erasmus Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DRUG:** Edoxaban

## Key facts

- **NCT ID:** NCT04171726
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171726, "Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04171726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*